Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02XEI
|
|||
| Former ID |
DIB003507
|
|||
| Drug Name |
DCVax-Ovarian
|
|||
| Synonyms |
DCVax-L; Dendritic cell-based immunotherapy (ovarian cancer), Northwest Biotherapeutics
Click to Show/Hide
|
|||
| Indication | Brain cancer [ICD-11: 2A00] | Phase 3 | [1] | |
| Pain [ICD-11: MG30-MG3Z] | Phase 3 | [2] | ||
| Recurrent glioblastoma [ICD-11: 2A00.00; ICD-10: C71] | Phase 3 | [3], [4], [5], [6] | ||
| Ovarian cancer [ICD-11: 2C73; ICD-10: C56; ICD-9: 183] | Phase 1 | [4] | ||
| Company |
Northwest biotherapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | ClinicalTrials.gov (NCT00045968) Study of a Drug [DCVax-L] to Treat Newly Diagnosed GBM Brain Cancer. U.S. National Institutes of Health. | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 4 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 5 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 6 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.